Showing results (641-650 of 3,096) with videos related to
Sort By:
Pageof 310
Expert Review of Anticancer Therapy|February 6, 2023
Developments in FGFR and IDH inhibitors for cholangiocarcinoma therapyZachary J Brown, Samantha M Ruff, Timothy M PawlikExpert Review of Anticancer Therapy|February 22, 2023
Clear cell sarcoma: state-of-the art and perspectivesLaureline Wetterwald, Nicolò Riggi, Anastasios Kyriazoglou, et al.Expert Review of Anticancer Therapy|November 14, 2022
Mucosa-associated lymphoid tissue lymphoma in thymus: a SEER analysisMeng-Xin Zhou, Ye-Ye Chen, Lei Liu, et al.Expert Review of Anticancer Therapy|December 7, 2025
Genomic divergence between matched primary and metastatic tumors across cancer types: a pan-cancer analysis of 5,692 samplesYakup ErgunExpert Review of Anticancer Therapy|November 10, 2012
Bevacizumab in combination with IFN-α in metastatic renal cell carcinoma: the AVOREN trialBohuslav Melichar, Hana Procházková-Študentová, Denisa VitáskováExpert Review of Anticancer Therapy|October 26, 2012
Exploring the efficacy and safety of single-agent sorafenib in a cohort of Italian patients with hepatocellular carcinomaDaniele Santini, Raffaele Addeo, Bruno Vincenzi, et al.Expert Review of Anticancer Therapy|October 27, 2012
Cabazitaxel in metastatic castration-resistant prostate cancerTimothy A Yap, Carmel J Pezaro, Johann S de BonoExpert Review of Anticancer Therapy|October 27, 2012
Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinomaAna Markovic, Christine H ChungExpert Review of Anticancer Therapy|October 27, 2012
Management of salivary gland tumorsGuy Andry, Marc Hamoir, Laura D Locati, et al.Expert Review of Anticancer Therapy|October 27, 2012
All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemiaRiccardo Masetti, Francesca Vendemini, Daniele Zama, et al.Pageof 310